Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Pefloxacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 8/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.90 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.90 |
| ▸ | HPGD | P15428 | 3/20 | 0.90 |
| ▸ | NPC1 | O15118 | 1/20 | 0.90 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.79 |
| ▸ | GAA | P10253 | 1/20 | 0.79 |
| ▸ | RAD52 | P43351 | 1/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | HTT | P42858 | 2/20 | 0.78 |
| ▸ | BRD4 | O60885 | 1/20 | 0.78 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.78 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.78 |
| ▸ | GLA | P06280 | 1/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pefloxacin SCHEMBL29351730 | 1.00 | DRD3 (1.00) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL28251251 | 1.00 | DRD3 (1.00) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL7861481 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL9788090 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL9800276 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL10911017 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL8184732 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL28542234 | 0.99 | DRD3 (0.98) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL29594648 | 0.95 | KDM4E (1.00) | DRD3MEN1KMT2AKDM4EALDH1A1 | |
| Pefloxacin SCHEMBL135085 | 0.95 | KDM4E (1.00) | DRD3MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13245 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122042636-A | Quick qualitative and quantitative analysis method for quinolone antibiotics in soil | 中国科学院城市环境研究所 | 2026-05-15 | — | — | CN | claimed |
| US-12624057-B2 | Bisphosphonate quinolone conjugates and uses thereof | BIOVINC, LLC (US) | 2026-05-12 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4434588-B1 | AEROSOL DELIVERY DEVICE | PARI PHARMA GMBH (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260090584-A1 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4659014-A1 | EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING | President And Fellows Of Harvard College (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-0255926-A2 | Antibacterial adhesive sheet and method for making it | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-02-17 | — | — | EP | claimed |
| EP-0228592-A2 | Bone cement | GMT Gesellschaft für medizinische Technik mbH (DE) | 1987-07-15 | — | — | EP | claimed |
| EP-0222814-A1 | USE OF QUINOLONE DERIVATIVES FOR THE TREATMENT OF MYCOPLASMAL PNEUMONIA IN PIGS | BEECHAM GROUP PLC (GB) | 1987-05-27 | — | — | EP | claimed |
| EP-0207624-A2 | Method for preparing infection-resistant materials | The Trustees of Columbia University in the City of New York (US) | 1987-01-07 | — | — | EP | claimed |
| WO-1986006630-A1 | USE OF QUINOLONE DERIVATIVES FOR THE TREATMENT OF MYCOPLASMAL PNEUMONIA IN PIGS | BEECHAM GROUP P.L.C. (GB) | 1986-11-20 | — | — | WO | claimed |
| US-4612337-A | SOAKING POLYMERIC MATERIAL WITH MICROBIOCIDE AND SOLVENT | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1986-09-16 | — | — | US | claimed |
| US-4563485-A | SURGICAL IMPLANTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1986-01-07 | — | — | US | claimed |
| US-4551456-A | BACTERICIDES | MERCK & CO., INC. (US) | 1985-11-05 | — | — | US | claimed |
| EP-0142426-A2 | Ophthalmic formulation containing norfloxacin and related antibiotics | MERCK & CO. INC. (US) | 1985-05-22 | — | — | EP | claimed |
| US-4292317-A | BACTERICIDES FOR GRAM NEGATIVE AND -POSITIVE BACTERIA; ANIMAL GROWTH REGULATORS | LABORATORIE ROGER BELLON (FR) | 1981-09-29 | — | — | US | claimed |